Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Assembly Biosciences Inc

ASMB
Current price
16.7 USD +0.65 USD (+4.02%)
Last closed 16.05 USD
ISIN US9228221019
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 106 467 856 USD
Yield for 12 month +83.32 %
1Y
3Y
5Y
10Y
15Y
ASMB
21.11.2021 - 28.11.2021

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. Address: Two Tower Place, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

35.5 USD

P/E ratio

Dividend Yield

Current Year

+7 163 000 USD

Last Year

Current Quarter

+6 845 000 USD

Last Quarter

+8 533 000 USD

Current Year

-41 737 000 USD

Last Year

-498 000 USD

Current Quarter

+6 845 000 USD

Last Quarter

+8 501 000 USD

Key Figures ASMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -50 267 000 USD
Operating Margin TTM -143.01 %
PE Ratio
Return On Assets TTM -34.72 %
PEG Ratio
Return On Equity TTM -101.78 %
Wall Street Target Price 35.5 USD
Revenue TTM 21 481 000 USD
Book Value 7.5 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM -63 895 000 USD
Earnings per share -6.89 USD
Diluted Eps TTM -6.89 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -212.33 %

Dividend Analytics ASMB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ASMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 12.02.2024
Dividend Date

Stock Valuation ASMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.4574
Price Sales TTM 4.9564
Enterprise Value EBITDA 0.4244
Price Book MRQ 4.0944

Financials ASMB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ASMB

For 52 weeks

8.43 USD 19.93 USD
50 Day MA 16.32 USD
Shares Short Prior Month 7 949
200 Day MA 14.76 USD
Short Ratio 0.41
Shares Short 11 545
Short Percent 0.38 %